DISCOVER THE COMPREHENSIVE PROCEDURE FOR CHRONIC RHINITIS

Deliver Lasting Relief from Chronic Rhinitis with RhinAer®

Watch Video
patient suffering from chronic rhinitis RhinAer® patient with chronic rhinitis relief

RhinAer  – A Comprehensive, Non-Invasive Solution for Chronic Rhinitis

For many patients struggling with chronic rhinitis, medical management does not provide the long-lasting relief they seek, and they remain tied to tissues and sprays to cope with their daily symptoms.

Most current, in-office rhinitis treatments are not comprehensive solutions, and surgical options like septoplasty, turbinate reduction, or other ablative technologies have mixed patient responses and may not alleviate all symptoms.

Compact and portable, the Aerin® Console and the RhinAer Stylus fit seamlessly into any clinic, office, or hospital environment. RhinAer is a convenient and efficient treatment option to integrate into your practice.

RhinAer® stylus console

RhinAer Treats the Causes of Chronic Rhinitis

RhinAer treats the root causes of rhinorrhea / post-nasal drip and congestion in a single session.

  • Disrupts the posterior nasal nerve (PNN) that triggers rhinitis
  • May be used to treat the full length of inferior turbinate to address congestion

The RhinAer stylus employs proprietary, temperature-controlled radiofrequency (RF) technology optimized for the nasal airway. Once the stylus is activated, the Aerin System automatically maintains the tip’s target temperature for therapeutic benefit while sparing surrounding tissue, including mucosa.

Patients undergoing the treatment experience minimal discomfort and recovery time.* In a recent study with the Aerin Console, there was no aerosol generation above background levels, thereby enhancing safety for physicians and staff.1

Who Benefits Most from the RhinAer Treatment?

  • Patients with moderate to severe chronic rhinorrhea, post-nasal drip, congestion, and/or chronic clearing of the throat
  • Allergy immunotherapy patients with continued drainage
  • Non-allergic chronic rhinitis patients
  • Post-FESS patients with uncontrolled rhinitis
RhinAer® 3d breakdown

The RhinAer Advantage

  • Disrupts posterior nasal nerve (PNN) that triggers rhinitis
  • May be used to treat full length of inferior turbinate
  • Incisionless and can be done under local anesthesia
  • Patients are typically able to return to normal activities the same day

The demonstrated relief your patients with chronic rhinitis deserve

1-Year results from the RhinAer pivotal trial2

RhinAer® responder rate at 52 weeks data

80.9% of patients experienced a significant (p<0.001) and sustained reduction in their chronic rhinitis symptoms through 52 weeks

RhinAer® rTNSS reduction data

57.6% overall rTNSS reduction with all rTNSS sub-scores (rhinorrhea, nasal congestion, nasal itching, and sneezing) measured statistically significant improvements (p<0.001) over baseline at 52 weeks

RhinAer® symptom reduction data

Mean post-nasal drip and chronic cough scores at baseline and follow-up. Bars represent 95% confidence intervals. All values were statistically significantly improved from baseline throughout follow‑up (p < .001 at all time points based on linear mixed-effect model).

Post-nasal drip and chronic cough symptom scores remained significantly improved from baseline at all follow-up time points (p<0.001)

† The Reflective Total Nose Symptom Score (rTNSS) is a validated patient reported outcome used to describe symptoms of rhinitis. The assessment consists of 4 nasal symptom domains (runny nose [rhinorrhea], itchy nose, sneezing, and stuffiness [nasal congestion]). Each item is rated from 0 (absent) to 3 (severe). The 4 domains are added together to provide an overall score ranging from 0 to 12.

RhinAer delivers symptom improvement in chronic rhinitis of allergic, non-allergic, and unknown etiologies

Treatment resulted in statistically significant mean rTNSS improvements for patients suffering from chronic rhinitis of allergic, non-allergic, and unknown etiologies (p<0.001)

RhinAer® symptom improvement data

RhinAer is a well-tolerated procedure that can be performed safely to reduce the symptoms of chronic rhinitis

0 serious adverse events related to the device and/or procedure were observed

0 device- or procedure-related headaches were reported through 52 weeks

Study design: Prospective, multi-center, non-randomized study was conducted to evaluate the safety and efficacy of the RhinAer® Stylus (RhinAer) on patients with chronic rhinitis symptoms for at least 6 months duration.

Patients: A total of 50 subjects were treated with RhinAer across 5 US centers and followed-up at 2, 4, 12, 26, and 52 weeks post-procedure.

Primary endpoint:

  • Change in rTNSS at baseline and 12 weeks post procedure
  • Percentage of participants with treatment-related adverse events (safety)

Download the full Clinical Summary

RhinAer® clinical summary

IMPROVED QUALITY OF LIFE WITH RHINAER

RhinAer® patient Janet

Janet

RhinAer Patient

“I feel like I can live again and do things I like to do. I’m not sneezing. I’m not blowing my nose. It’s just amazing."

Interested in Learning More?

* Individual results may vary

References:

  1. LeConte et. al. Aerosol generation with common rhinologic devices: Cadaveric study conducted in a surgical suite. [published online ahead of print 07 August 2020]. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.22679
  2. Ehmer D, McDuffie CM, Scurry WC, et al. Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Rhinitis. American Journal of Rhinology & Allergy. August 2021. doi:10.1177/19458924211033400

1 Console, 2 Powerful Treatments

The RhinAer Stylus plugs into the compact and portable Aerin® Console. The console may also be used with the VivAer® Stylus to treat the entire nasal valve and provide lasting relief for patients suffering from nasal airway obstruction.

VivAer.com
Aerin console